Testicular cancer in blacks. A multicenter experience

Area of Science:

• Oncology
• Epidemiology
• Urologic Oncology

Background:

• Testis tumors are rare in Black patients, leading to limited large-scale studies.
• Epidemiologic and clinical data for this population are often debated.
• Key areas of dispute include incidence, prognosis, histology, and presentation demographics.

Purpose of the Study:

• To investigate the characteristics and outcomes of testicular tumors in Black patients.
• To compare findings in Black patients with the general testicular cancer population.
• To assess the impact of treatment advancements on this demographic.

Main Methods:

• Retrospective review of 66 Black patients with testicular tumors.
• Data collected from seven military medical centers.
• Comparison with existing data from the general testicular cancer population.

Main Results:

• Prognosis, side distribution, and age of onset for nonseminoma and interstitial tumors are similar to the general population.
• A slight increase in interstitial tumors was observed in Black patients.
• Black patients with seminoma presented at a younger mean age.
• Diagnosis delays were longer in Black patients compared to White patients.
• Incidence did not increase in Black patients between 1979-1991, unlike White patients.
• Cisplatin-based chemotherapy improved prognosis for Black patients.

Conclusions:

• Testis tumors in Black patients largely mirror the general population's behavior.
• Key differences include a higher incidence of interstitial tumors and younger age at seminoma presentation.
• Increased diagnostic delays in Black patients were noted.
• The incidence of testis tumors in Black patients is not rising.
• Cisplatin-based chemotherapy has significantly enhanced survival rates for Black patients.